HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patrizia Vici Selected Research

fluorocholine

11/2021A Prospective Study Assessing the Post-Prostatectomy Detection Rate of a Presumed Local Failure at mpMR with Either 64CuCl2 or 64CuPSMA PET/CT.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patrizia Vici Research Topics

Disease

100Breast Neoplasms (Breast Cancer)
05/2024 - 06/2002
68Neoplasms (Cancer)
03/2024 - 06/2002
12Triple Negative Breast Neoplasms
03/2024 - 01/2015
11Neoplasm Metastasis (Metastasis)
11/2021 - 08/2011
9Ovarian Neoplasms (Ovarian Cancer)
01/2020 - 08/2013
7Disease Progression
05/2024 - 08/2013
7Male Breast Neoplasms (Male Breast Cancer)
10/2016 - 08/2013
6Uterine Cervical Neoplasms (Cancer of the Cervix)
04/2021 - 01/2014
5Stomach Neoplasms (Stomach Cancer)
09/2022 - 09/2013
4Ovarian Epithelial Carcinoma
01/2016 - 08/2013
3Pathologic Complete Response
01/2023 - 01/2020
3Cardiotoxicity
01/2023 - 01/2014
3Carcinoma (Carcinomatosis)
04/2020 - 02/2008
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2020 - 01/2019
2Neutropenia
10/2022 - 10/2005
2Adenocarcinoma of Lung
12/2021 - 11/2019
2Obesity
11/2020 - 10/2016
2COVID-19
08/2020 - 01/2020
2Colonic Neoplasms (Colon Cancer)
04/2020 - 01/2019
2Brain Neoplasms (Brain Tumor)
04/2020 - 01/2019
2Head and Neck Neoplasms (Head and Neck Cancer)
04/2020 - 01/2017
2Ataxia Telangiectasia (Louis Bar Syndrome)
11/2019 - 01/2019
2Rare Diseases (Rare Disease)
08/2017 - 11/2014
2Residual Neoplasm
12/2015 - 06/2002
1Clinical Deterioration
10/2023

Drug/Important Bio-Agent (IBA)

25Hormones (Hormone)IBA
01/2023 - 02/2008
18Trastuzumab (Herceptin)FDA Link
01/2023 - 04/2013
15AnthracyclinesIBA
09/2020 - 06/2002
13Biomarkers (Surrogate Marker)IBA
11/2022 - 02/2004
10EverolimusFDA Link
06/2022 - 01/2016
10Phenobarbital (Luminal)FDA Link
06/2022 - 10/2014
9Taxoids (Taxanes)IBA
01/2023 - 03/2008
9Immune Checkpoint InhibitorsIBA
12/2021 - 11/2017
8human ERBB2 proteinIBA
11/2023 - 10/2014
8pertuzumabIBA
01/2023 - 01/2015
8eribulinFDA Link
10/2022 - 01/2014
8Estrogen ReceptorsIBA
01/2021 - 10/2014
8exemestane (Aromasin)FDA Link
12/2020 - 01/2017
8Epirubicin (Ellence)FDA LinkGeneric
04/2011 - 03/2002
7Progesterone Receptors (Progesterone Receptor)IBA
01/2021 - 10/2014
6Capecitabine (Xeloda)FDA Link
01/2023 - 04/2013
6Aromatase InhibitorsIBA
02/2020 - 08/2011
6Bevacizumab (Avastin)FDA Link
01/2019 - 01/2016
6Docetaxel (Taxotere)FDA Link
10/2014 - 04/2004
6Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2011 - 06/2002
5palbociclibIBA
12/2023 - 01/2019
5DNA (Deoxyribonucleic Acid)IBA
10/2023 - 12/2015
5Fulvestrant (Faslodex)FDA Link
11/2021 - 08/2017
5PlatinumIBA
04/2020 - 08/2013
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 01/2014
5Glucose (Dextrose)FDA LinkGeneric
02/2018 - 11/2014
5GemcitabineFDA Link
08/2013 - 04/2004
4Lapatinib (GW572016)FDA Link
06/2022 - 04/2013
4Estrogens (Estrogen)FDA Link
01/2021 - 01/2013
4Phosphotransferases (Kinase)IBA
11/2019 - 01/2016
4Monoclonal AntibodiesIBA
01/2019 - 01/2016
4Gonadotropin-Releasing Hormone (GnRH)FDA Link
05/2015 - 08/2013
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2014 - 09/2003
4Vinorelbine (Navelbine)FDA LinkGeneric
04/2011 - 06/2002
3Cyclin-Dependent Kinase 4IBA
01/2023 - 12/2020
3ribociclibIBA
11/2022 - 01/2021
3Proteins (Proteins, Gene)FDA Link
10/2022 - 01/2019
3Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2021 - 09/2017
3Ado-Trastuzumab EmtansineIBA
01/2021 - 01/2017
3Indicators and Reagents (Reagents)IBA
11/2020 - 01/2015
3VaccinesIBA
10/2020 - 03/2014
3TamoxifenFDA LinkGeneric
01/2019 - 02/2008
3ErbB Receptors (EGF Receptor)IBA
01/2019 - 04/2013
3Antineoplastic Agents (Antineoplastics)IBA
01/2019 - 02/2015
3Paclitaxel (Taxol)FDA LinkGeneric
01/2018 - 03/2011
3Androgen Antagonists (Antiandrogens)IBA
11/2015 - 11/2014
3lonidamineIBA
07/2006 - 09/2003
2taxaneIBA
03/2024 - 01/2019
2N-acetyltalosaminuronic acid (NAT)IBA
10/2023 - 01/2017
2Letrozole (Femara)FDA LinkGeneric
11/2022 - 08/2013
2Epidermal Growth Factor (EGF)IBA
11/2022 - 01/2021
2AndrogensIBA
11/2021 - 11/2015
2NivolumabIBA
04/2020 - 01/2019
2Oncogene Proteins (Oncogene Protein)IBA
06/2016 - 01/2016
2Tyrosine Kinase InhibitorsIBA
01/2016 - 04/2013
2Metformin (Glucophage)FDA LinkGeneric
01/2016 - 05/2015
2Insulin (Novolin)FDA Link
01/2016 - 05/2015
2Androgen Receptors (Androgen Receptor)IBA
11/2015 - 11/2014
2Cyproterone AcetateIBA
05/2015 - 11/2014
2Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2014 - 08/2013
2Fertility AgentsIBA
01/2014 - 02/2013
2liposomal doxorubicin (Doxil)FDA Link
01/2014 - 04/2011
2Filgrastim (Neupogen)FDA Link
10/2005 - 01/2004
1Circulating Tumor DNAIBA
10/2023
1CyclinsIBA
01/2023

Therapy/Procedure

59Therapeutics
05/2024 - 02/2004
38Drug Therapy (Chemotherapy)
09/2022 - 06/2002
21Neoadjuvant Therapy
03/2024 - 06/2002
7Immunotherapy
01/2022 - 03/2014
5Radiotherapy
01/2023 - 10/2020
3Drug Tapering
12/2023 - 01/2021
2Duration of Therapy
12/2023 - 01/2022
2Adjuvant Chemotherapy
09/2022 - 10/2014
2Combination Drug Therapy (Combination Chemotherapy)
03/2015 - 10/2014
1Modified Radical Mastectomy (Mastectomy, Modified)
01/2023